Factors associated with time to follow-up of severe hyperkalemia in the ambulatory setting

American Journal of Medical Quality

Volumn 22, Issue 6, 2007, Pages 428-437

  Moore, Carlton ^a   Lin, Jenny ^a   McGinn, Thomas ^a   Halm, Ethan ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Abnormal tests; Ambulatory; Follow up; Hyperkalemia; Medical errors

Indexed keywords

AGED; ARTICLE; FEMALE; HOSPITALIZATION; HUMAN; HYPERKALEMIA; MALE; MEDICAL AUDIT; MIDDLE AGED; OUTPATIENT DEPARTMENT; PATIENT CARE; PROPORTIONAL HAZARDS MODEL; UNITED STATES;

AGED; AGED, 80 AND OVER; AMBULATORY CARE FACILITIES; CONTINUITY OF PATIENT CARE; FEMALE; HUMANS; HYPERKALEMIA; MALE; MEDICAL AUDIT; MIDDLE AGED; NEW YORK CITY; PROPORTIONAL HAZARDS MODELS; SEVERITY OF ILLNESS INDEX;

EID: 36149000970     PISSN: 10628606     EISSN: 1555824X     Source Type: Journal    
DOI: 10.1177/1062860607305245     Document Type: Article

References (22)

1. Plews-Ogan ML, Nadkarni MM, Forren S., et al. Patient safety in the ambulatory setting. J Gen Intern Med. 2004 ; 19: 719-725.
2. Ahrq. Patient fact sheet: 20 tips to help prevent medical error. Available at: http://www.ahrq.gov/consumer/20tips.htm. Accessed July 2006.
3. Poon EG, Gandhi TK, Sequist TD, Murff HJ, Karson AS, Bates DW " I wish I had seen this test result earlier!": Dissatisfaction with test result management systems in primary care. Arch Intern Med. 2004 ; 164: 2223-2228.
4. Boohaker EA, Ward RE, Uman JE, McCarthy BD Patient notification and follow-up of abnormal test results. A physician survey. Arch Intern Med. 1996 ; 156: 327-331.
5. Lin JJ, Dunn A., Moore C. Follow-up of outpatient test results: a survey of house-staff practices and perceptions. Am J Med Qual. 2006 ; 21: 178-184.
6. Schepkens H., Vanholder R., Billiouw JM, Lameire N. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases. Am J Med. 2001 ; 110: 438-441.
7. Reardon LC, Macpherson DS Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry? Arch Intern Med. 1998 ; 158: 26-32.
8. Perazella MA, Mahnensmith RL Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasis. J Gen Intern Med. 1997 ; 12: 646-656.
9. Juurlink DN, Mamdani MM, Lee DS, et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med. 2004 ; 351: 543-551.
10. Blake J., Devereux RB Differential effects of direct antagonism of AII compared to ACE inhibitors on serum potassium levels and azotemia in patients with severe congestive heart failure. Congest Heart Fail. 2000 ; 6: 193-196.
11. Charytan D., Goldfarb DS Indications for hospitalization of patients with hyperkalemia. Arch Intern Med. 2000 ; 160: 1605-1611.
12. Rimmer JM, Horn JF, Gennari FJ Hyperkalemia as a complication of drug therapy. Arch Intern Med. 1987 ; 147: 867-869.
13. Acker CG, Johnson JP, Palevsky PM, Greenberg A. Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med. 1998 ; 158: 917-924.
14. Rose BD Clinical manifestations and treatment of hyperkalemia. UpToDate [online]. Version 15.1. 2007. Available at: http://www.uptodateonline.com/utd/ index.do. Accessed May 2006.
15. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003 ; 289: 1107-1116.
16. Gandhi TK, Weingart SN, Borus J., et al. Adverse drug events in ambulatory care. N Engl J Med. 2003 ; 348: 1556-1564.
17. Poon EG, Haas JS, Louise Puopolo A, et al. Communication factors in the follow-up of abnormal mammograms. J Gen Intern Med. 2004 ; 19: 316-323.
18. Kravitz RL, Rolph JE, Petersen L. Omission-related malpractice claims and the limits of defensive medicine. Med Care Res Rev. 1997 ; 54: 456-471.
19. Chang SW, Kerlikowske K., Napoles-Springer A., Posner SF, Sickles EA, Perez-Stable EJ Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer. 1996 ; 78: 1395-1402.
20. Jones BA, Dailey A., Calvocoressi L., et al. Inadequate follow-up of abnormal screening mammograms: findings from the Race Differences in Screening Mammography Process study (United States). Cancer Causes Control. 2005 ; 16: 809-821.
21. Reason J. Human Error. Cambridge, UK: Cambridge University Press ; 1990: 199-212.
22. Poon EG, Wang SJ, Gandhi TK, Bates DW, Kuperman GJ Design and implementation of a comprehensive outpatient Results Manager. J Biomed Inform. 2003 ; 36: 80-91.